The Sjogren’s syndrome market is expected to be mainly driven by the increasing prevalence of the disease, along with the promising emerging pipeline therapies with a new mechanism of action, will fuel the Sjogren’s syndrome market. LAS VEGAS, Jan. 16, 2024 /PRNewswire/ — DelveInsight’s…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.